Results 1 to 10 of about 4,533,022 (343)

Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period

Nature Communications, 2022
Although severe COVID-19 in children is rare, they may develop multisystem inflammatory syndrome, long-COVID and downstream effects of COVID-19, including social isolation and disruption of education. Data on the effectiveness of the CoronaVac vaccine is
P. Florentino, F. J. Alves, T. Cerqueira-Silva, V. A. Oliveira, J. B. Junior, A. G. Jantsch, G. Penna, V. Boaventura, G. Werneck, L. C. Rodrigues, N. Pearce, M. Barral-Netto, M. Barreto, E. Paixão   +13 more
semanticscholar   +1 more source

Vaccination side effects [PDF]

British Dental Journal, 2021
Dziedzic, A., Tanasiewicz, M.
openaire   +2 more sources

Factors associated with parental intentions to vaccinate 0-4-year-old children against COVID-19 in Canada: a cross-sectional study using the Childhood COVID-19 Immunization Coverage Survey (CCICS)

BMC Public Health
Background The objective of this study was to determine the factors associated with low or no parental intention to vaccinate children of 0-4-years in Canada with a COVID-19 vaccine through the 2022 Childhood COVID-19 Immunization Coverage Survey (CCICS).
Israa Zareef, Anna-Maria Frescura, Sailly Dave, Caren Uhlik, David Guan, Hussein Samhat, Marwa Ebrahim, Julie Laroche   +7 more
doaj   +1 more source

Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs. [PDF]

, 2018
BACKGROUND: Human papillomavirus (HPV) vaccines were first licensed as a three-dose series; a two-dose series is now recommended in some age groups and there is interest in possible one-dose vaccination.
Brisson, Marc, Drolet, Melanie, Jit, Mark, Markowitz, Lauri E, Perez, Norma   +4 more
core   +1 more source

Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021

Vaccine, 2021
In Belgium, high-risk contacts of an infected person were offered PCR-testing irrespective of their vaccination status. We estimated vaccine effectiveness (VE) against infection and onwards transmission, controlling for previous infections, household ...
T. Braeye, L. Cornelissen, L. Catteau, Freek Haarhuis, K. Proesmans, K. de Ridder, Achille Djiena, R. Mahieu, F. De Leeuw, Alex Dreuw, N. Hammami, S. Quoilin, H. Van Oyen, C. Wyndham-Thomas, D. van Cauteren   +14 more
semanticscholar   +1 more source

A Method for Reducing the Severity of Epidemics by Allocating Vaccines According to Centrality

, 2014
One long-standing question in epidemiological research is how best to allocate limited amounts of vaccine or similar preventative measures in order to minimize the severity of an epidemic.
Fu S., Hagberg A. A., Indrakanti S., Johnson T. V., Merrill R. M.   +4 more
core   +1 more source

Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method : experience across the 2010/11 season [PDF]

, 2013
Aim: This study examines estimation of seasonal influenza vaccine effectiveness (VE) for a cohort of patients attending general practice in Scotland in 2010/11.
Kavanagh, Kimberley, McMenamin, Jim, Robertson, Charles   +2 more
core   +3 more sources

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

Nature Communications, 2021
The UK prioritised delivery of the first dose of BNT162b2 (Pfizer/BioNTech) and AZD1222 (AstraZeneca) vaccines by extending the interval between doses up to 12 weeks.
G. Amirthalingam, J. L. Bernal, N. Andrews, H. Whitaker, C. Gower, J. Stowe, E. Tessier, S. Subbarao, G. Ireland, F. Baawuah, E. Linley, L. Warrener, Michelle O'Brien, C. Whillock, P. Moss, S. Ladhani, K. Brown, M. Ramsay   +17 more
semanticscholar   +1 more source

An assessment of measles vaccine effectiveness, Australia, 2006-2012

Western Pacific Surveillance and Response, 2015
Objective: Vaccine effectiveness analysis serves as a critical evaluation for immunization programmes and vaccination coverage. It also contributes to maintaining public confidence with the vaccine providers.
Alexis Pillsbury, Helen Quinn
doaj   +1 more source

Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities

medRxiv, 2021
Vaccinations are considered the major tool to curb the current SARS-CoV-2 pandemic. A randomized placebo-controlled trial of the BNT162b2 vaccine has demonstrated a 95% efficacy in preventing COVID-19 disease.
I. Yelin, R. Katz, E. Herzel, T. Berman-Zilberstein, A. Ben-Tov, J. Kuint, S. Gazit, T. Patalon, G. Chodick, R. Kishony   +9 more
semanticscholar   +1 more source